Cevimeline Hydrochloride Capsule
Product Images NDC 72888-118

Each capsule contains 30 mg of cevimeline hydrochloride, which is available in pack size NDC 72888-118-00. The labeling instructs users to refer to the package insert for cevimeline dosage and administration details. These capsules should be stored in a tightly sealed container at temperatures ranging from 20° to 25°C. Excursions are allowed between 15°C and 30°C. Dispensed capsules should always be kept away from children. Advagen Pharma Limited is responsible for distribution, while Rubicon Research Private Limited is responsible for manufacturing. The package was revised on 12/22 21536 with an overprinting area of 60 mm x 30 mm.*

Each capsule contains 30 mg of cevimeline hydrochloride and should be stored between 20°C to 25°C (68°F to 77°F) with permitted excursions between 15°C to 30°C (59°F to 86°F). The NDC number is 72888-118-30 and the product is distributed by Advagen Pharma Limited at 666 Plainsboro Road Suite 605, Plainsboro, NJ, 08536, USA. The manufacturer is Rubicon Research Private Limited at Ambernath, Dist. Thane, 421506 India. The package insert should be consulted for dosage and administration instructions. The medication should be kept out of reach of children and dispensed in a tight container. The manufacturer's licensing number is KD-682 21538.*

Each capsule of Advagen Pharma Limited's Cevimeline contains 30 mg of cevimeline hydrochloride. It is available in a container of 500 capsules and is only available through prescription. Dosage and Administration instructions can be found in the package insert. Store the capsules at a temperature between 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F ) and dispense in a tightly closed container. Keep it away from children. The product is marked with NDC number 72888-118-05, and the manufacturer is Rubicon Research Private Limited located in India with manufacturing license number KD-682. Information about overprinting is available as well.*